SHC Sotera Healthdata gap · 92% coverage
Health Care · Health Care Services · close $17.89 (2026-10-16) · latest quarter in EDGAR: 2026-06-30
Sotera Health (SHC) has a ThetaGrade House Rating of 54/100 (grade C), ranking #124 of 150 in Health Care. Its strongest pillars are growth (65) and profitability (65); its weakest is balance sheet (31). Data gap: 2 factors without usable data, so 92% of the method weight is covered. TTM revenue growth is 8.1% and operating margin 35.2%.
Data as of .
Data gap
No usable data for: Consensus score (1–5), 90-day net rating shift. Data gap: no usable data for this factor, so it is left out and its weight is shared among the factors that do have data (no value is imputed). 92% of the full method weight is backed by data.
Analyst sentiment
weight 7.5% · no data · —| Consensus score (1–5) (0.0%)data gap | derived | — |
| 90-day net rating shift (0.0%)data gap | derived | — |
Growth
weight 30.83% (→33.3%) · 65| Revenue growth YoY (TTM) (13.3%) | 8.1% | 40 |
| EPS growth YoY (TTM) (13.3%) | 533.3% | 97 |
| Revenue acceleration (6.7%) | -0.8% | 49 |
Profitability
weight 18.5% (→20.0%) · 65| Operating margin (10.7%) | 35.2% | 93 |
| 4Q gross-margin change (9.3%) | -0.6% | 33 |
Balance sheet
weight 18.5% (→20.0%) · 31| Net debt / EBITDA (10.7%) | 3.41× | 21 |
| Current ratio (5.3%) | 2.80 | 52 |
| Interest coverage (4.0%) | 2.61× | 31 |
Cash flow
weight 12.33% (→13.3%) · 52| FCF margin (6.7%) | 12.8% | 52 |
| FCF yield (6.7%) | 2.9% | 51 |
Valuation
weight 12.33% (→13.3%) · 50| P/E (inverted) (6.7%) | 31.39× | 49 |
| EV/Sales (inverted) (6.7%) | 5.66× | 51 |
Technicals (EOD)
| RSI(14) | 43.0 |
| EMA 9 / 21 | 18.05 / 18.24 |
| 200-day SMA | 17.02 |
| Volume vs 20d avg | 0.91× |
| 20-day return | -5.6% |
Exit-rule monitor
- EXITRating break: House Rating below 60
Data source per metric (SEC XBRL tag or derivation): Revenue: RevenueFromContractWithCustomerExcludingAssessedTax · Gross profit: GrossProfit · Operating income: Pretax income + fiscal-year interest expense (EBIT proxy) · Interest expense: InterestPaidNet · D&A: DepreciationDepletionAndAmortization · EPS: EarningsPerShareDiluted · Market cap: SEC shares (dei EntityCommonStockSharesOutstanding (cover page)) × EOD close · P/E: EOD close ÷ SEC TTM EPS (EarningsPerShareDiluted).
Get rating changes like SHC's in the free Daily Brief
The market’s key events and signals, digested before the open.
- ✓ Pre-market Daily Brief: events, headlines, rating changes (2-min read)
- ✓ Sunday: Top 5 Weekly Picks, exit alerts, CSP put watchlist
- ✓ OPEX, FOMC, CPI and jobs-day reminders
Free. Want more? See Premium (waitlist).
FAQ
- What is SHC's House Rating?
- SHC scores 54 out of 100 (grade C) as of 2026-10-16, ranking #124 of 150 Health Care stocks we cover.
- What do analysts say about SHC?
- We do not have enough analyst-sentiment data to score this stock.
- When does SHC report earnings next?
- SHC's next earnings report is estimated for about 2026-11-03 (window 2026-10-29 to 2026-11-08), based on its past SEC 8-K earnings filings. This is an estimate, not a company-confirmed date.
- Is SHC a buy?
- ThetaGrade does not give personal advice. The House Rating is an educational, rules-based summary of public data; see the methodology for how it is built.
Sources: SEC EDGAR filings (fetched 2026-10-18), Finnhub recommendation trends, Massive EOD prices. Scores are sector percentiles; a factor without usable data is a data gap: it is left out and the remaining weights are renormalized (nothing is imputed). Educational only. Methodology